Cubist Systematic Strategies, LLC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 184 filers reported holding ACORDA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 4.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$22,000
-8.3%
23,517
+97.2%
0.00%
Q4 2019$24,000
-77.8%
11,928
-68.3%
0.00%
-100.0%
Q3 2019$108,000
-83.4%
37,663
-55.7%
0.00%
-83.3%
Q2 2019$652,000
-65.4%
84,980
-40.1%
0.01%
-80.3%
Q1 2019$1,887,000
+546.2%
141,980
+657.8%
0.06%
+335.7%
Q4 2018$292,000
-49.6%
18,737
-36.4%
0.01%
-56.2%
Q3 2018$579,000
+164.4%
29,470
+285.8%
0.03%
+190.9%
Q2 2018$219,000
-84.5%
7,639
-87.2%
0.01%
-86.7%
Q1 2018$1,416,000
+227.0%
59,878
+190.3%
0.08%
+167.7%
Q1 2017$433,000
+136.6%
20,627
+111.5%
0.03%
+106.7%
Q4 2016$183,000
+19.6%
9,752
+33.2%
0.02%
+50.0%
Q3 2016$153,000
-53.1%
7,323
-42.7%
0.01%
-47.4%
Q2 2016$326,000
-18.1%
12,775
-15.1%
0.02%
-17.4%
Q1 2016$398,000
-73.6%
15,051
-57.3%
0.02%
-73.9%
Q4 2015$1,507,000
+115.6%
35,222
+33.7%
0.09%
+151.4%
Q3 2015$699,000
+153.3%
26,353
+218.5%
0.04%
+169.2%
Q2 2015$276,000
-73.9%
8,273
-74.0%
0.01%
-75.0%
Q1 2015$1,058,000
+645.1%
31,786
+816.0%
0.05%
+550.0%
Q4 2014$142,000
-66.3%
3,470
-72.1%
0.01%
-69.2%
Q3 2014$421,000
+146.2%
12,431
+144.6%
0.03%
+160.0%
Q2 2014$171,0005,0830.01%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,045,400$21,953,00012.28%
SCOPIA CAPITAL MANAGEMENT LP 5,568,306$116,934,0002.16%
GREAT POINT PARTNERS LLC 432,500$9,083,0001.80%
Consonance Capital Management LP 619,419$13,008,0001.36%
RA Capital Management 489,828$10,286,0001.26%
Ghost Tree Capital, LLC 300,000$6,300,0001.17%
DLD Asset Management, LP 281,900$5,920,0000.95%
DLD Asset Management, LP 281,900$5,914,0000.95%
Worth Venture Partners, LLC 36,650$770,0000.68%
Malaga Cove Capital, LLC 51,013$939,0000.57%
View complete list of ACORDA THERAPEUTICS INC shareholders